NYLIM
ANGO icon

New York Life Investment Management’s AngioDynamics ANGO Stock Holding History

New York Life Investment Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-33,529
Closed -$263K – 1340
2023
Q4 		$263K Sell
33,529
-905
-3% -$6.28K ﹤0.01% 1258
2023
Q3 		$252K Sell
34,434
-5,424
-14% -$45.1K ﹤0.01% 1238
2023
Q2 		$416K Buy
39,858
+1,974
+5% +$19K ﹤0.01% 937
2023
Q1 		$392K Buy
+37,884
New +$485K ﹤0.01% 1149

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

New York Life Investment Management's ANGO Position: Q1 2024 in Review

New York Life Investment Management sold out of AngioDynamics (ANGO) in Q1 2024, closing a stake of 33,529 shares — an estimated $263K sold.

New York Life Investment Management first reported a position in ANGO in Q1 2023 and held it in 4 quarters. The position peaked at $416K in Q2 2023. 135 funds tracked by Wall St. Rank hold ANGO as of Q1 2024.

  • New York Life Investment Management reported no remaining AngioDynamics position as of Q1 2024 after selling out during the quarter.
  • New York Life Investment Management sold 33,529 AngioDynamics shares in Q1 2024, an estimated $263K.
  • New York Life Investment Management first reported a position in AngioDynamics in Q1 2023 and held it in 4 quarters.
  • New York Life Investment Management's AngioDynamics position peaked at $416K in Q2 2023.
  • 135 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.